価格表

在庫・価格 : 2025年09月02日 04時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Calnexin, Rabbit-Poly
データシート
NB100-1965 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 ml ¥96,000
(未発注)
追加

在庫・価格 : 2025年09月02日 04時43分 現在

Anti-Calnexin, Rabbit-Poly

  • 商品コード:NB100-1965
  • メーカー:NOV
  • 包装:0.1ml
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Imperatore R et al. Immunohistochemical Analysis of Intestinal and Central Nervous System Morphology in an Obese Animal Model (<i>Danio rerio</i>) Treated with 3,5-T2: A Possible Farm Management Practice? Animals (Basel) 2020 Jul;10(7)
Imperatore R et al
2020/01/01
PubMed
2 Musante L et al. Rigorous characterization of urinary extracellular vesicles (uEVs) in the low centrifugation pellet - a neglected source for uEVs. Sci Rep 2020 02;10(1):3701
Musante L et al
2020/01/01
PubMed
3 Xu Y et al. Hepatocyte-Specific Expression of Human Carboxylesterase 1 Attenuates Diet-Induced Steatohepatitis and Hyperlipidemia in Mice. Hepatol Commun 2020 Apr;4(4):527-539
Xu Y et al
2020/01/01
PubMed
4 Khalaj K et al. Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature. JCI Insight 2019 09;4(18)
Khalaj K et al
2019/01/01
PubMed
5 Jo Y et al. Enhanced ER-associated degradation of HMG CoA reductase causes embryonic lethality associated with <i>Ubiad1</i> deficiency. Elife 2020 03;9
Jo Y et al
2020/01/01
PubMed
6 Xu Y et al. Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis. Mol Ther 2020 01;28(1):202-216
Xu Y et al
2020/01/01
PubMed
7 Millan C et al. Extracellular Vesicles from 3D Engineered Microtissues Harbor Disease-Related Cargo Absent in EVs from 2D Cultures. Adv Healthc Mater 2021 Apr;:e2002067
Millan C et al
2021/01/01
PubMed
8 Xu Y et al. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. Mol Metab 2021 Sep;51:101244
Xu Y et al
2021/01/01
PubMed
9 Qi X et al. Sterols in an intramolecular channel of Smoothened mediate Hedgehog signaling. Nat Chem Biol 2020 12;16(12):1368-1375
Qi X et al
2020/01/01
PubMed
10 Xu Y et al. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism. Nat Metab 2021 01;3(1):59-74
Xu Y et al
2021/01/01
PubMed
11 Xu Y et al. Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4&#x3B1;. Diabetes 2021 Nov;70(11):2506-2517
Xu Y et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Imperatore R et al. Immunohistochemical Analysis of Intestinal and Central Nervous System Morphology in an Obese Animal Model (<i>Danio rerio</i>) Treated with 3,5-T2: A Possible Farm Management Practice? Animals (Basel) 2020 Jul;10(7)
    Imperatore R et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Musante L et al. Rigorous characterization of urinary extracellular vesicles (uEVs) in the low centrifugation pellet - a neglected source for uEVs. Sci Rep 2020 02;10(1):3701
    Musante L et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Xu Y et al. Hepatocyte-Specific Expression of Human Carboxylesterase 1 Attenuates Diet-Induced Steatohepatitis and Hyperlipidemia in Mice. Hepatol Commun 2020 Apr;4(4):527-539
    Xu Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Khalaj K et al. Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature. JCI Insight 2019 09;4(18)
    Khalaj K et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Jo Y et al. Enhanced ER-associated degradation of HMG CoA reductase causes embryonic lethality associated with <i>Ubiad1</i> deficiency. Elife 2020 03;9
    Jo Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Xu Y et al. Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis. Mol Ther 2020 01;28(1):202-216
    Xu Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Millan C et al. Extracellular Vesicles from 3D Engineered Microtissues Harbor Disease-Related Cargo Absent in EVs from 2D Cultures. Adv Healthc Mater 2021 Apr;:e2002067
    Millan C et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Xu Y et al. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. Mol Metab 2021 Sep;51:101244
    Xu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Qi X et al. Sterols in an intramolecular channel of Smoothened mediate Hedgehog signaling. Nat Chem Biol 2020 12;16(12):1368-1375
    Qi X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Xu Y et al. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism. Nat Metab 2021 01;3(1):59-74
    Xu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Xu Y et al. Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4&#x3B1;. Diabetes 2021 Nov;70(11):2506-2517
    Xu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed